Promising Dual Immunotherapy for Anaplastic Thy...

By Rene Pretorius

January 10, 2025

We review the results from the phase 2 nonrandomized clinical trial on the clinical activity of dual immune checkpoint inhibition in aggressive thyroid cancer. The purpose of the study was to...
Valuable, Cost-Effective Thyroid Cancer Diagnosis
WHO Prequalifies First G6PD Diagnostic Test
Cultural Challenges Hindering AI in Maternal Healthcare in Africa
Advancing Newborn Screening for Sickle Cell Disease in Africa
Diabetes Drugs Safe from Thyroid Cancer Risk, Study Finds
Abu Dhabi Introduces WINREVAIR: A Major Breakthrough in Pulmonary Arterial Hy...
Thyroid Eye Disease Therapy: Insights from Viridian Therapeutics’ THRIV...
Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prev...
Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak
BioSapien Innovative Cancer Drug Delivery Solutions
Lenacapavir Injection: A Breakthrough in Global HIV Prevention
Transforming Cancer Care in Abu Dhabi